title: Surgical treatment of thymic tumors.
abstract: Thymoma is a rare neoplasm usually with an indolent growth pattern; however, local invasion and/or metastases may occur. The association with several paraneoplastic syndromes, especially myasthenia gravis, makes thymoma an interesting biologic tumor model. Surgery has been the standard of care for early stage disease with high cure rates anticipated. Multimodality therapy can result in long-term disease-free survival for patients presenting with locally advanced disease.
authors.affiliation: Massachusetts General Hospital, Harvard Medical School, Section of Thoracic Surgery, Blake 1570, 55 Fruit Street, Boston, Massachusetts 02114, USA. wright.cameron@mgh.harvard.edu
authors.forename: Cameron D
authors.initials: CD
authors.lastname: Wright
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Kessler
mesh_terms: D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D011379:Prognosis; D018570:Risk Assessment; D016019:Survival Analysis; D020775:Thoracic Surgery, Video-Assisted / Q000379:methods; D013908:Thoracotomy / Q000379:methods; D013934:Thymectomy / Q000009:adverse effects / Q000379:methods*; D013945:Thymoma / Q000401:mortality / Q000473:pathology* / Q000601:surgery*; D013953:Thymus Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery*; D016896:Treatment Outcome